Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Xylem Inc.xyl06302016ex321.htm
EX-32.2 - EXHIBIT 32.2 - Xylem Inc.xyl06302016ex322.htm
EX-31.2 - EXHIBIT 31.2 - Xylem Inc.xyl06302016ex312.htm
EX-31.1 - EXHIBIT 31.1 - Xylem Inc.xyl06302016ex311.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2016
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from             to             
Commission file number: 1-35229
Xylem Inc.
(Exact name of registrant as specified in its charter)
 
Indiana
  
45-2080495
(State or other jurisdiction of incorporation or
organization)
  
(I.R.S. Employer Identification No.)
1 International Drive, Rye Brook, NY 10573
(Address of principal executive offices) (Zip code)
(914) 323-5700
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ   No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
þ
 
Accelerated filer
 
¨
 
 
 
 
 
 
Non-accelerated filer
 
¨  (Do not check if a smaller reporting company)
 
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨    No  þ
As of July 29, 2016, there were 179,181,591 outstanding shares of the registrant’s common stock, par value $0.01 per share.
 



Xylem Inc.
Table of Contents
ITEM
  
  
PAGE
PART I – Financial Information
 
Item 1
-
 
 
 
 
 
 
 
 
 
 
 
Item 2
-
Item 3
-
Item 4
-
PART II – Other Information
 
Item 1
-
Item 1A
-
Item 2
-
Item 3
-
Item 4
-
Item 5
-
Item 6
-
 

2


PART I

XYLEM INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

ITEM 1.             CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)

 
Three Months
 
Six Months
For the period ended June 30,
2016
 
2015
 
2016
 
2015
Revenue
$
932

 
$
920

 
$
1,779

 
$
1,757

Cost of revenue
563

 
572

 
1,081

 
1,094

Gross profit
369

 
348

 
698

 
663

Selling, general and administrative expenses
227

 
218

 
446

 
424

Research and development expenses
27

 
25

 
52

 
48

Restructuring charges
6

 
1

 
12

 
4

Operating income
109

 
104

 
188

 
187

Interest expense
20

 
14

 
34

 
28

Other non-operating income, net
1

 
1

 
1

 

Gain from sale of businesses

 

 

 
9

Income before taxes
90

 
91

 
155

 
168

Income tax expense
19

 
17

 
18

 
30

Net income
$
71

 
$
74

 
$
137

 
$
138

Earnings per share:
 
 
 
 
 
 
 
Basic
$
0.39

 
$
0.41

 
$
0.77

 
$
0.76

Diluted
$
0.39

 
$
0.41

 
$
0.76

 
$
0.76

Weighted average number of shares:
 
 
 
 
 
 
 
Basic
179.1

 
181.5

 
178.8

 
181.8

Diluted
179.9

 
182.3

 
179.6

 
182.7

Dividends declared per share
$
0.1549

 
$
0.1408

 
$
0.3098

 
$
0.2816

See accompanying notes to condensed consolidated financial statements.


3


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(in millions)
 
 
Three Months
 
Six Months
For the period ended June 30,
2016
 
2015
 
2016
 
2015
Net income
$
71

 
$
74

 
$
137

 
$
138

Other comprehensive (loss) income, before tax:
 
 
 
 
 
 
 
Foreign currency translation adjustment
(29
)
 
26

 
(17
)
 
(103
)
Foreign currency gain reclassified into net income

 

 

 
(8
)
Net change in derivative hedge agreements:
 
 
 
 
 
 
 
Unrealized losses
(4
)
 

 

 
(5
)
Amount of (gain) loss reclassified into net income
(1
)
 
7

 
(1
)
 
12

Net change in postretirement benefit plans:
 
 
 
 
 
 
 
Amortization of net actuarial loss into net income
2

 
4

 
5

 
8

Other comprehensive (loss) income, before tax
(32
)
 
37

 
(13
)
 
(96
)
Income tax impact related to items of other comprehensive income
8

 
2

 
1

 
3

Other comprehensive (loss) income, net of tax
(40
)
 
35

 
(14
)
 
(99
)
Comprehensive income
$
31

 
$
109

 
$
123

 
$
39

See accompanying notes to condensed consolidated financial statements.

4


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
 
 
June 30,
2016
 
December 31,
2015
 
 
 
 
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
586

 
$
680

Receivables, less allowances for discounts and doubtful accounts of $26 and $33 in 2016 and 2015, respectively
784

 
749

Inventories
483

 
433

Prepaid and other current assets
154

 
143

Total current assets
2,007

 
2,005

Property, plant and equipment, net
438

 
439

Goodwill
1,616

 
1,584

Other intangible assets, net
453

 
435

Other non-current assets
180

 
194

Total assets
$
4,694

 
$
4,657

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
339

 
$
338

Accrued and other current liabilities
390

 
407

Short-term borrowings and current maturities of long-term debt
91

 
78

Total current liabilities
820

 
823

Long-term debt
1,143

 
1,196

Accrued postretirement benefits
336

 
335

Deferred income tax liabilities
117

 
118

Other non-current accrued liabilities
104

 
101

Total liabilities
2,520

 
2,573

Commitments and contingencies (Note 17)

 

Stockholders’ equity:
 
 
 
Common Stock – par value $0.01 per share:
 
 
 
Authorized 750.0 shares, issued 191.1 shares and 190.2 shares in 2016 and 2015, respectively
2

 
2

Capital in excess of par value
1,860

 
1,834

Retained earnings
966

 
885

Treasury stock – at cost 11.9 shares and 11.8 shares in 2016 and 2015, respectively
(402
)
 
(399
)
Accumulated other comprehensive loss
(252
)
 
(238
)
Total stockholders’ equity
2,174

 
2,084

Total liabilities and stockholders’ equity
$
4,694

 
$
4,657


See accompanying notes to condensed consolidated financial statements.

5


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
For the six months ended June 30,
2016
 
2015
Operating Activities
 
 
 
Net income
$
137

 
$
138

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
41

 
47

Amortization
24

 
22

Share-based compensation
10

 
8

Restructuring charges
12

 
4

Gain from sale of businesses

 
(9
)
Other, net
8

 
3

Payments for restructuring
(6
)
 
(9
)
Changes in assets and liabilities (net of acquisitions):
 
 
 
Changes in receivables
(19
)
 
(28
)
Changes in inventories
(39
)
 
(27
)
Changes in accounts payable
9

 
3

Other, net
(52
)
 
(29
)
Net Cash – Operating activities
125

 
123

Investing Activities
 
 
 
Capital expenditures
(62
)
 
(57
)
Acquisition of business, net of cash acquired
(70
)
 

Proceeds from sale of businesses

 
1

Other, net
5

 
3

Net Cash – Investing activities
(127
)
 
(53
)
Financing Activities
 
 
 
Short-term debt issued
89

 

  Short-term debt repaid
(77
)
 
(2
)
Long-term debt issued
540

 

  Long-term debt repaid
(608
)
 

Repurchase of common stock
(3
)
 
(53
)
Proceeds from exercise of employee stock options
16

 
9

Dividends paid
(56
)
 
(51
)
Other, net
1

 
1

Net Cash – Financing activities
(98
)
 
(96
)
Effect of exchange rate changes on cash
6

 
(37
)
Net change in cash and cash equivalents
(94
)
 
(63
)
Cash and cash equivalents at beginning of year
680

 
663

Cash and cash equivalents at end of period
$
586

 
$
600

Supplemental disclosure of cash flow information:
 
 
 
Cash paid during the period for:
 
 
 
Interest
$
34

 
$
26

Income taxes (net of refunds received)
$
49

 
$
42


See accompanying notes to condensed consolidated financial statements.

6


Note 1. Background and Basis of Presentation
Background
Xylem Inc. ("Xylem" or the "Company") is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. Xylem was incorporated in Indiana on May 4, 2011.
Xylem operates in two segments, Water Infrastructure and Applied Water. The Water Infrastructure segment focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment serves many of the primary uses of water and focuses on the residential, commercial, industrial and agriculture markets. The Applied Water segment’s major products include pumps, valves, heat exchangers, controls and dispensing equipment.
Except as otherwise indicated or unless the context otherwise requires, "Xylem," "we," "us," "our" and the "Company" refer to Xylem Inc. and its subsidiaries.
Basis of Presentation
The interim condensed consolidated financial statements reflect our financial position and results of operations in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany transactions between our businesses have been eliminated.
The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position and results of operations for the periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2015 ("2015 Annual Report") in preparing these unaudited condensed consolidated financial statements, with the exception of accounting standard updates described in Note 2. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our 2015 Annual Report.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, postretirement obligations and assets, revenue recognition, income tax contingency accruals and valuation allowances, goodwill and indefinite lived intangible impairment testing and contingent liabilities. Actual results could differ from these estimates.
Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the condensed consolidated financial statements included herein are described as ending on the last day of the calendar quarter.
Note 2. Recently Issued Accounting Pronouncements
Pronouncements Not Yet Adopted
In June 2016, the Financial Accounting Standards Board (“FASB”) issued guidance amending the accounting for the impairment of financial instruments, including trade receivables. Under current guidance, credit losses are recognized when the applicable losses are probable of occurring and this assessment is based on past events and current conditions. The amended guidance eliminates the “probable” threshold and requires an entity to use a broader range of information, including forecast information when estimating expected credit losses. Generally, this should result in a more timely recognition of credit losses. This guidance is effective for interim and annual periods beginning after December 15, 2019 with early adoption permitted for interim and annual periods beginning after December 15, 2018. The requirements of the amended guidance should be applied using a modified retrospective approach except for debt securities, which require a prospective transition approach. We are evaluating the impact of the guidance on our financial condition and results of operations.

7


In February 2016, the FASB issued guidance amending the accounting for leases. Specifically, the amended guidance requires all lessees to record a lease liability at lease inception, with a corresponding right of use asset, except for short-term leases. Lessor accounting is not fundamentally changed. This amended guidance is effective for interim and annual periods beginning after December 15, 2018 using a modified retrospective approach. Early adoption is permitted. We are evaluating the impact of the guidance on our financial condition and results of operations.
In July 2015, the FASB issued guidance regarding simplifying the measurement of inventory. Under prior guidance, inventory is measured at the lower of cost or market, where market is defined as replacement cost, with a ceiling of net realizable value and a floor of net realizable value less a normal profit margin. The amended guidance requires the measurement of inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. This guidance is effective prospectively for interim and annual periods beginning after December 15, 2016 and early application is permitted. We are evaluating the impact of the guidance on our financial condition and results of operations.
In May 2014, the FASB issued guidance on recognizing revenue from contracts with customers. The guidance outlines a single comprehensive model to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the model is that an entity recognizes revenue to portray the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also expands disclosure requirements regarding revenue recognition. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017 and may be applied retrospectively to each prior period presented or with the cumulative effect recognized as of the date of initial application. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2016. We are evaluating the impact of the guidance on our financial condition and results of operations.
Recently Adopted Pronouncements
In March 2016, the FASB issued an update on accounting for share-based payments.  The guidance simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification of excess tax benefits in the Condensed Consolidated Statements of Cash Flows. This standard is effective for annual reporting periods beginning after December 15, 2016. The Company elected to early adopt this standard in the quarter ended June 30, 2016 retroactively to January 1, 2016. The impact of the early adoption resulted in the following:
The Company recorded tax benefits of $2 million within income tax expense for the three and six months ended June 30, 2016, related to the excess tax benefit on share-based awards. Prior to adoption this amount would have been recorded as an increase of capital in excess of par value. This change could create volatility in the Company's effective tax rate.
The Company no longer reflects the cash received from the excess tax benefit within cash flows from financing activities but instead now reflects this benefit within cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows. The Company elected to apply this change in presentation prospectively and thus prior periods have not been adjusted.
The Company elected not to change its policy on accounting for forfeitures and continues to estimate the total number of awards for which the requisite service period will not be rendered.
At this time, the Company has not changed its policy on statutory withholding requirements and will continue to allow the employee to withhold up to the Company's minimum statutory withholding requirements.
The Company excluded the excess tax benefits from the assumed proceeds available to repurchase shares in the computation of our diluted earnings per share for the three and six months ended June 30, 2016. This increased diluted weighted average common shares outstanding by less than 50,000 shares for each of the aforementioned periods.
In March 2016, the FASB amended the guidance regarding the use of the equity method to record certain investments. Under current guidance, if an investor increases its level of ownership interest in a company and consequently qualifies for the equity method, the investor must retroactively adjust its investment, results of operations and retained earnings to reflect balances that would have arisen if the equity method had been in

8


effect during all previous periods that the investment was held. The amended guidance eliminates the need to retroactively adjust balances and instead allows for the prospective application of the equity method. This guidance is effective prospectively for interim and annual reporting periods beginning after December 15, 2016. We elected to early adopt this guidance effective the first quarter of 2016. The adoption of this guidance did not impact our financial condition or results of operations.
In March 2016, in response to inconsistency in practice, the FASB issued guidance regarding the ability to maintain hedge accounting for a derivative instruments when one party to the instrument has been replaced by a new party (“a novation”). The new guidance states that a novation does not preclude the continued application of hedge accounting to a derivative assuming all other hedge accounting criteria continue to be met. This guidance is effective using either a prospective or a modified retrospective approach, for interim and annual reporting periods beginning after December 15, 2016. We elected to early adopt this guidance on a prospective basis effective the first quarter of 2016. The adoption of this guidance did not impact our financial condition or results of operations.
In March 2016, the FASB issued guidance clarifying what steps need to be followed when evaluating if call or put options are not clearly and closely related to their debt hosts, and therefore must be accounted for as separate derivatives. The guidance prescribes a four step process to assess whether an event that triggers the ability to exercise a call or put option is clearly and closely related to the debt host. The four step decision sequence requires an entity to consider whether (1) the payoff is adjusted based on changes in an index; (2) the payoff is indexed to an underlying other than interest rates or credit risk; (3) the debt involves a substantial premium or discount; and (4) the call or put option is contingently exercisable. This guidance is effective using a modified retrospective approach, for interim and annual reporting periods beginning after December 15, 2016. We elected to early adopt this guidance effective the first quarter of 2016. The adoption of this guidance did not impact our financial condition or results of operations.
Note 3. Acquisitions and Divestitures
On February 1, 2016, we acquired Tideland Signal Corporation (“Tideland”), a leading producer of analytics solutions in the coastal and ocean management sectors, for $70 million.  Tideland, a privately-owned company headquartered in Texas, has approximately 160 employees and annual revenue of approximately $48 million. Our condensed consolidated financial statements include Tideland’s results of operations from February 1, 2016 within the Water Infrastructure segment.
There were no divestitures for the three months ended June 30, 2015. For the six months ended June 30, 2015, we divested two businesses for $1 million, which were not material, individually or in the aggregate, to our results of operations or financial position. The sales resulted in a gain of $9 million, reflected in gain from sale of businesses in our Condensed Consolidated Income Statement.
Note 4. Restructuring Charges
From time to time, the Company will incur costs related to restructuring actions in order to optimize our cost base and more strategically position ourselves based on the economic environment and customer demand. During the three and six months ended June 30, 2016, we recognized restructuring charges of $6 million and $12 million, respectively. We incurred these charges primarily in an effort to reposition our European and North American businesses to optimize our cost structure and improve our operational efficiency and effectiveness. The charges included the reduction of headcount and consolidation of facilities within our Applied Water and Water Infrastructure segments, as well as Corporate headcount reductions.
During the three and six months ended June 30, 2015, we recognized restructuring charges of $1 million and $4 million, respectively. We incurred these charges primarily in an effort to reposition our European and North American businesses to optimize our cost structure and improve our operational efficiency and effectiveness. The charges included the reduction of headcount and consolidation of facilities within our Water Infrastructure segment.

9


The following table presents the components of restructuring expense.
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(in millions)
2016
 
2015
 
2016
 
2015
By component:
 
 
 
 
 
 
 
Severance and other charges
$
6

 
$
1

 
$
12

 
$
5

Reversal of restructuring accruals

 

 

 
(1
)
Total restructuring charges
$
6

 
$
1

 
$
12

 
$
4

 
 
 
 
 
 
 
 
By segment:
 
 
 
 
 
 
 
Water Infrastructure
$
5

 
$
1

 
$
7

 
$
4

Applied Water
1

 

 
3

 

      Corporate and other

 

 
2

 

The following table displays a rollforward of the restructuring accruals, presented on our Condensed Consolidated Balance Sheets within accrued and other current liabilities, for the six months ended June 30, 2016 and 2015.
(in millions)
 
2016
 
2015
Restructuring accruals - January 1
 
$
3

 
$
12

Restructuring charges
 
12

 
4

Cash payments
 
(6
)
 
(9
)
Foreign currency and other
 

 
(1
)
Restructuring accruals - June 30
 
$
9

 
$
6

 
 
 
 
 
By segment:
 
 
 
 
Water Infrastructure
 
$
5

 
$
3

Applied Water
 
1

 

Regional selling locations (a)
 
1

 
3

Corporate and other
 
2

 

(a)
Regional selling locations consist primarily of selling and marketing organizations that incurred restructuring expense which was allocated to the segments. The liabilities associated with restructuring expense were not allocated to the segments.
The following is a rollforward for the six months ended June 30, 2016 and 2015 of employee position eliminations associated with restructuring activities.
 
 
2016
 
2015
Planned reductions - January 1
 
82

 
133

Additional planned reductions
 
223

 
80

Actual reductions
 
(203
)
 
(106
)
Planned reductions - June 30
 
102

 
107

Total expected costs associated with actions that commenced during 2016 are approximately $14 million for Water Infrastructure, including $7 million incurred during the six months ended June 30, 2016. These costs primarily consist of severance charges. We currently expect activity related to these actions to continue through the end of 2017. Total expected costs associated with actions that commenced during 2016 are approximately $6 million for Applied Water, including $3 million incurred during the six months ended June 30, 2016. These costs primarily consist of severance charges. We currently expect activity related to these actions to continue through the end of 2017. Total expected costs associated with actions that commenced during 2016 are approximately $2

10


million for Corporate, which we incurred during the six months ended June 30, 2016. These costs primarily consist of severance charges.
Total expected costs associated with actions that commenced during 2015 are approximately $5 million for Water Infrastructure. Approximately $4 million of the expected cost was incurred in 2015 and no additional costs were incurred during the six months ended June 30, 2016. We currently expect activity related to these actions to continue through the third quarter of 2016. Total expected costs associated with actions that commenced during 2015 are approximately $1 million for Applied Water. These costs primarily consist of severance charges and substantially all of the costs associated with these actions were incurred in 2015.
Note 5. Income Taxes
Our quarterly provision for income taxes is measured using an estimated annual effective tax rate, adjusted for discrete items within periods presented. The comparison of our effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and discrete items.
The income tax provision for the three months ended June 30, 2016 was $19 million resulting in an effective tax rate of 21.6%, compared to $17 million resulting in an effective tax rate of 18.1% for the same period in 2015. The income tax provision for the six months ended June 30, 2016 was $18 million resulting in an effective tax rate of 11.8%, compared to $30 million resulting in an effective tax rate of 17.8% for the same period in 2015. The effective tax rate was lower than the United States federal statutory rate primarily due to geographic mix of earnings in both periods as well as a reduction in the amount of unrecognized tax benefits recorded as a result of the effective settlement of a tax examination in the first quarter of 2016.
Unrecognized Tax Benefits
We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
The amount of unrecognized tax benefits at June 30, 2016 was $27 million which, if ultimately recognized, will reduce our annual effective tax rate. We do not believe that the unrecognized tax benefits will significantly change within the next twelve months.
We classify interest expense relating to unrecognized tax benefits as a component of other non-operating expense, net, and tax penalties as a component of income tax expense in our Condensed Consolidated Income Statements. As of June 30, 2016, we had $2 million of interest accrued for unrecognized tax benefits.

11


Note 6. Earnings Per Share
The following is a reconciliation of the shares used in calculating basic and diluted net earnings per share.
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2016
 
2015
 
2016
 
2015
Net income (in millions)
$
71

 
$
74

 
$
137

 
$
138

Shares (in thousands):
 
 
 
 
 
 
 
Weighted average common shares outstanding
179,020

 
181,422

 
178,790

 
181,735

Add: Participating securities (a)
46

 
52

 
38

 
49

Weighted average common shares outstanding — Basic
179,066

 
181,474

 
178,828

 
181,784

Plus incremental shares from assumed conversions: (b)
 
 
 
 
 
 
 
Dilutive effect of stock options
459

 
513

 
396

 
522

Dilutive effect of restricted stock units and performance-based shares
365

 
326

 
377

 
382

Weighted average common shares outstanding — Diluted
179,890

 
182,313

 
179,601

 
182,688

Basic earnings per share
$
0.39

 
$
0.41

 
$
0.77

 
$
0.76

Diluted earnings per share
$
0.39

 
$
0.41

 
$
0.76

 
$
0.76

(a)
Restricted stock unit awards containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.
(b)
Incremental shares from stock options, restricted stock units and performance-based shares are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock units and performance-based shares, reduced by the repurchase of shares with the proceeds from the assumed exercises and unrecognized compensation expense for outstanding awards. Performance-based shares will be included in the treasury stock calculation of diluted earnings per share upon achievement of underlying performance or market conditions. See Note 14, "Share-Based Compensation Plans" to the condensed consolidated financial statements for further detail on the performance-based shares.
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(in thousands)
2016
 
2015
 
2016
 
2015
Stock options
2,068

 
2,800

 
2,161

 
2,717

Restricted stock units
582

 
633

 
591

 
612

Performance-based shares
409

 
213

 
334

 
186

Note 7. Inventories
The components of total inventories are summarized as follows: 
(in millions)
June 30,
2016
 
December 31,
2015
Finished goods
$
220

 
$
213

Work in process
37

 
32

Raw materials
226

 
188

Total inventories
$
483

 
$
433


12


Note 8. Property, Plant and Equipment
The components of total property, plant and equipment, net are as follows:
(in millions)
June 30,
2016
 
December 31,
2015
Land, buildings and improvements
$
244

 
$
240

Machinery and equipment
647

 
650

Equipment held for lease or rental
216

 
205

Furniture and fixtures
80

 
79

Construction work in progress
56

 
46

Other
19

 
19

Total property, plant and equipment, gross
1,262

 
1,239

Less accumulated depreciation
824

 
800

Total property, plant and equipment, net
$
438

 
$
439

Depreciation expense of $21 million and $41 million was recognized in the three and six months ended June 30, 2016, respectively, and $23 million and $47 million for the three and six months ended June 30, 2015.
Note 9. Goodwill and Other Intangible Assets
Goodwill    
Changes in the carrying value of goodwill by reportable segment for the six months ended June 30, 2016 are as follows:
(in millions)
Water
Infrastructure
 
Applied Water
 
Total
Balance as of January 1, 2016
$
1,066

 
$
518

 
$
1,584

Activity in 2016
 
 
 
 
 
Acquired (a)
36

 

 
36

Foreign currency and other
(3
)
 
(1
)
 
(4
)
Balance as of June 30, 2016
$
1,099

 
$
517

 
$
1,616

(a)
On February 1, 2016, we acquired Tideland and recorded $36 million of goodwill. Refer to Note 3, "Acquisitions and Divestitures" for additional information.
Other Intangible Assets
Information regarding our other intangible assets is as follows:
 
June 30, 2016
 
December 31, 2015
(in millions)
Carrying
Amount
 
Accumulated
Amortization
 
Net
Intangibles
 
Carrying
Amount
 
Accumulated
Amortization
 
Net
Intangibles
Customer and distributor relationships
$
342

 
$
(153
)
 
$
189

 
$
320

 
$
(140
)
 
$
180

Proprietary technology and patents
118

 
(57
)
 
61

 
116

 
(54
)
 
62

Trademarks
43

 
(21
)
 
22

 
35

 
(19
)
 
16

Software
165

 
(116
)
 
49

 
155

 
(110
)
 
45

Other
8

 
(8
)
 

 
8

 
(8
)
 

Indefinite-lived intangibles
132

 

 
132

 
132

 

 
132

 
$
808

 
$
(355
)
 
$
453

 
$
766

 
$
(331
)
 
$
435

Amortization expense related to finite-lived intangible assets was $12 million and $24 million for the three and six months ended June 30, 2016, respectively, and $11 million and $22 million for the three and six months ended June 30, 2015, respectively.

13


Note 10. Derivative Financial Instruments
Risk Management Objective of Using Derivatives
We are exposed to certain risks arising from both our business operations and economic conditions, and principally manage our exposures to these risks through management of our core business activities. Certain of our foreign operations expose us to fluctuations of foreign interest rates and exchange rates that may impact revenue, expenses, cash receipts, cash payments, and the value of our stockholders' equity. We enter into derivative financial instruments to protect the value or fix the amount of certain cash flows in terms of the functional currency of the business unit with that exposure and reduce the volatility in stockholders' equity.
Cash Flow Hedges of Foreign Exchange Risk
We are exposed to fluctuations in various foreign currencies against our functional currencies. We use foreign currency derivatives, including currency forward agreements, to manage our exposure to fluctuations in the various exchange rates. Currency forward agreements involve fixing the foreign currency exchange rate for delivery of a specified amount of foreign currency on a specified date.
Certain business units with exposure to foreign currency exchange risks have designated certain currency forward agreements as cash flow hedges of forecasted intercompany inventory purchases and sales. Our principal currency exposures relate to the Euro, Swedish Krona, British Pound, Canadian Dollar, Polish Zloty and Australian Dollar. We held forward foreign exchange contracts with purchase notional amounts totaling $125 million and $94 million as of June 30, 2016 and December 31, 2015, respectively. As of June 30, 2016, our most significant foreign currency derivatives include contracts to purchase Swedish Krona and sell Euro, sell US Dollar and purchase Euro, sell Canadian Dollar and purchase US Dollar, sell Canadian Dollar and purchase Euro, and purchase Polish Zloty and sell Euro. The purchased notional amounts associated with these currency derivatives are $57 million, $44 million, $9 million, $7 million, and $7 million, respectively. As of December 31, 2015, our most significant foreign currency derivatives included contracts to purchase Swedish Krona and sell Euro, sell U.S. Dollar and purchase Euro, and to sell British Pound and purchase Euro. The purchased notional amounts associated with these currency derivatives are $51 million, $24 million and $12 million, respectively.
Hedges of Net Investments in Foreign Operations
We are exposed to changes in foreign currencies impacting our net investments held in foreign subsidiaries.
Cross Currency Swaps
Beginning in 2015, we entered into cross currency swaps to manage our exposure to fluctuations in the Euro-U.S. Dollar exchange rate. The total notional amount of derivative instruments designated as net investment hedges was $416 million and $411 million as of June 30, 2016 and December 31, 2015, respectively.
Foreign Currency Denominated Debt
On March 11, 2016, we issued 2.250% Senior Notes of €500 million aggregate principal amount due March 2023. We designated the entirety of the outstanding balance, or $550 million, net of unamortized discount, as a hedge of a net investment in certain foreign subsidiaries.

14


The table below presents the effect of our derivative financial instruments on the Condensed Consolidated Income Statements and Statements of Comprehensive Income. 
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(in millions)
2016
 
2015
 
2016
 
2015
Cash Flow Hedges
 
 
 
 
 
 
 
Foreign Exchange Contracts
 
 
 
 
 
 
 
Amount of (loss) recognized in OCI (a)
$
(4
)
 
$

 
$

 
$
(5
)
Amount of (gain) loss reclassified from OCI into revenue (a)
(1
)
 
7

 

 
11

Amount of (gain) loss reclassified from OCI into cost of revenue (a)

 

 
(1
)
 
1

 
 
 
 
 
 
 
 
Net Investment Hedges
 
 
 
 
 
 
 
Cross Currency Swaps
 
 
 
 
 
 
 
Amount of gain recognized in OCI (a)
$
11

 
$

 
$

 
$

Foreign Currency Denominated Debt
 
 
 
 
 
 
 
Amount of gain (loss) recognized in OCI (a)
$
10

 
$

 
$
(5
)
 
$

(a)
Effective portion
As of June 30, 2016, no net unrealized gains or losses on cash flow hedges are expected to be reclassified into earnings in the next 12 months. The ineffective portion of a cash flow hedge is recognized immediately in selling, general and administrative expenses in the Condensed Consolidated Income Statements and was not material for the three and six months ended June 30, 2016 and 2015.
As of June 30, 2016, no gains or losses on the net investment hedges are expected to be reclassified into earnings over their duration. The net investment hedges did not experience any ineffectiveness for the three and six months ended June 30, 2016.
The fair values of our derivative assets and liabilities are measured on a recurring basis using Level 2 inputs and are determined through the use of models that consider various assumptions including yield curves, time value and other measurements.
The fair values of our foreign exchange contracts currently included in our hedging program designated as hedging instruments were as follows:
(in millions)
June 30,
2016
 
December 31,
2015
Derivatives designated as hedging instruments
 
 
 
Assets
 
 
 
Cash Flow Hedges
 
 
 
  Other current assets
$
1

 
$
2

Liabilities
 
 
 
Cash Flow Hedges
 
 
 
  Other current liabilities
$
(2
)
 
$

Net Investment Hedges
 
 
 
Other non-current liabilities
$
(22
)
 
$
(18
)
The fair value of our long-term debt, due in 2023, designated as a net investment hedge was $596 million as of June 30, 2016.

15


Note 11. Accrued and Other Current Liabilities
The components of total accrued and other current liabilities are as follows:
(in millions)
June 30,
2016
 
December 31,
2015
Compensation and other employee benefits
$
155

 
$
156

Customer-related liabilities
64

 
64

Accrued warranty costs
32

 
33

Accrued taxes
54

 
64

Other accrued liabilities
85

 
90

Total accrued and other current liabilities
$
390

 
$
407

Note 12. Credit Facilities and Debt
Total debt outstanding is summarized as follows:
(in millions)
June 30,
2016
 
December 31,
2015
3.550% Senior Notes due 2016
$

 
$
600

4.875% Senior Notes due 2021 (a)
600

 
600

2.250% Senior Notes due 2023 (a)
556

 

Commercial paper
50

 

Research and development facility agreement
41

 
76

Other

 
2

Debt issuance costs and unamortized discount (b)
(13
)
 
(4
)
Total debt
1,234

 
1,274

Less: short-term borrowings and current maturities of long-term debt
91

 
78

Total long-term debt
$
1,143

 
$
1,196

(a)
The fair value of our Senior Notes (as defined below) was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2021 was $659 million and $640 million as of June 30, 2016 and December 31, 2015, respectively. The fair value of our Senior Notes due 2023 was $596 million as of June 30, 2016.
(b)
The debt issuance costs and unamortized discount are recognized as a reduction in the carrying value of the Senior Notes in the Condensed Consolidated Balance Sheets and are being amortized to interest expense in our Condensed Consolidated Income Statements over the expected remaining terms of the Senior Notes.
Senior Notes
On September 20, 2011, we issued 3.550% Senior Notes of $600 million aggregate principal amount due September 2016 (the "Senior Notes due 2016") and 4.875% Senior Notes of $600 million aggregate principal amount due October 2021 (the "Senior Notes due 2021"). On March 11, 2016, we issued 2.250% Senior Notes of €500 million aggregate principal amount due March 2023 (the "Senior Notes due 2023" and together with the Senior Notes due 2016 and 2021, the "Senior Notes").
The Senior Notes include covenants which restrict our ability, subject to exceptions, to incur debt secured by liens and engage in sale and leaseback transactions, as well as provide for customary events of default (subject, in certain cases, to receipt of notice of default and/or customary grace and cure periods). We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. We may redeem all or a portion of the Senior Notes due 2023 at our option at any time on or after December 11, 2022 (three months prior to their maturity), at a redemption price equal to 100% of the principal amount, plus accrued and unpaid interest to the redemption date.  We may also redeem all, but not part, of the Senior Notes due 2023 in the event of specified tax events as described in the applicable Senior Notes indenture. If a change of control triggering event (as defined in the applicable Senior Notes indenture) occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase. As of

16


June 30, 2016, we were in compliance with all covenants for the Senior Notes.
Interest on the Senior Notes due 2016 was payable on March 20 and September 20 of each year. Interest on the Senior Notes due 2021 is payable on April 1 and October 1 of each year. Interest on the Senior Notes due 2023 is payable on March 11 of each year.
On April 11, 2016, our Senior Notes due 2016 were settled for a total of $607 million which included make-whole interest expense of $7 million. The Company recorded this loss on extinguishment of the debt in the second quarter of 2016 as interest expense.
Five-Year Revolving Credit Facility
Effective March 27, 2015, Xylem entered into a Five-Year Revolving Credit Facility (the "Credit Facility") with Citibank, N.A., as administrative agent, and a syndicate of lenders. The Credit Facility provides for an aggregate principal amount of up to $600 million of: (i) revolving extensions of credit (the "revolving loans") outstanding at any time and (ii) the issuance of letters of credit in a face amount not in excess of $100 million outstanding at any time. The Credit Facility provides for increases of up to $200 million for a possible maximum total of $800 million in aggregate principal amount at our request and with the consent of the institutions providing such increased commitments.
At our election, the interest rate per annum applicable to the revolving loans will be based on either (i) a Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, plus an applicable margin or (ii) a fluctuating rate of interest determined by reference to the greatest of: (a) the prime rate of Citibank, N.A., (b) the U.S. Federal funds effective rate plus half of 1% or (c) the Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, in each case, plus an applicable margin.
In accordance with the terms, we may not exceed a maximum leverage ratio of 3.50 to 1.00 (based on a ratio of total debt to earnings before interest, taxes, depreciation and amortization) throughout the term. The Credit Facility also contains limitations on, among other things, incurring secured debt, granting liens, entering into sale and leaseback transactions, mergers, consolidations, liquidations, dissolutions and sales of assets. In addition, the Credit Facility contains other terms and conditions such as customary representations and warranties, additional covenants and customary events of default. As of June 30, 2016, we were in compliance with all covenants.
As of June 30, 2016, the Credit Facility was undrawn.
Research and Development Facility Agreement
On December 3, 2015, the Company amended and restated its Risk Sharing Finance Facility Agreement (the "R&D Facility Agreement") with The European Investment Bank (the "EIB") to amend the maturity date. The facility provides an aggregate principal amount of up to €120 million (approximately $133 million) to finance research projects and infrastructure development in the European Union. The Company's wholly owned subsidiaries in Luxembourg, Xylem Holdings S.á r.l. and Xylem International S.á r.l., are the borrowers under the R&D Facility Agreement.  The obligations of the borrowers under the R&D Facility Agreement are guaranteed by the Company under an Amended and Restated Deed of Guarantee, dated as of December 4, 2013, in favor of the EIB. The funds are available during the period from 2013 through 2016 at the Company's facilities in Sweden, Germany, Italy, the United Kingdom, Austria, Norway and Hungary.
Under the R&D Facility Agreement, the borrower was able to draw loans on or before March 31, 2016 with a maturity of no longer than 12 years. The R&D Facility Agreement provides for Fixed Rate loans and Floating Rate loans. The interest rate per annum applicable to Fixed Rate loans is at a fixed percentage rate per annum specified by the EIB which includes the applicable margin. The interest rate per annum applicable to Floating Rate loans is at the rate determined by reference to EURIBOR for loans drawn in Euros and LIBOR for loans drawn in Pounds Sterling or U.S. Dollars, plus an applicable spread specified by the EIB which includes the applicable margin. The applicable margin for both Fixed Rate loans and Floating Rate loans is determined by reference to the credit rating of the Company.

17


In accordance with the terms of the R&D Facility Agreement, we may not exceed a maximum leverage ratio of 3.50 to 1.00 (based on a ratio of total debt to earnings before interest, taxes, depreciation and amortization) throughout the term. The R&D Facility Agreement also contains limitations on, among other things, incurring debt, granting liens, and entering into sale and leaseback transactions. In addition, the R&D Facility Agreement contains other terms and conditions, such as customary representations and warranties, additional covenants and customary events of default. As of June 30, 2016, we were in compliance with all covenants.
As of June 30, 2016 and December 31, 2015, $41 million and $76 million was outstanding, respectively, under the R&D Facility Agreement. Although the borrowing term for this arrangement is up to five years, we have classified it as short-term debt on our Condensed Consolidated Balance Sheet since we intend to repay this obligation in less than a year.
Commercial Paper
Our commercial paper program generally serves as a means of short-term funding. As of June 30, 2016, $50 million of the Company’s $600 million commercial paper program was outstanding at a weighted average interest rate of 0.76%. We will periodically borrow under this program and may borrow under it in future periods.
Note 13. Postretirement Benefit Plans
The components of net periodic benefit cost for our defined benefit pension plans are as follows:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(in millions)
2016
 
2015
 
2016
 
2015
Domestic defined benefit pension plans:
 
 
 
 
 
 
 
Service cost
$
1

 
$
1

 
$
1

 
$
1

Interest cost
1

 
1

 
2

 
2

Expected return on plan assets
(1
)
 
(1
)
 
(2
)
 
(2
)
Amortization of net actuarial loss

 

 
1

 
1

Net periodic benefit cost
$
1

 
$
1

 
$
2

 
$
2

International defined benefit pension plans:
 
 
 
 
 
 
 
Service cost
$
2

 
$
3

 
$
5

 
$
6

Interest cost
6

 
6

 
12

 
12

Expected return on plan assets
(8
)
 
(9
)
 
(17
)
 
(17
)
Amortization of net actuarial loss
2

 
4

 
4

 
7

Net periodic benefit cost
$
2

 
$
4

 
$
4

 
$
8

Total net periodic benefit cost
$
3

 
$
5

 
$
6

 
$
10

The total net periodic benefit cost for other postretirement employee benefit plans was $1 million and $2 million including amounts recognized in other comprehensive income ("OCI") of less than $1 million for both the three and six months ended June 30, 2016, respectively. The total net periodic benefit cost for other postretirement employee benefit plans was $1 million and $2 million including amounts recognized in OCI of less than $1 million for both the three and six months ended June 30, 2015, respectively.
We contributed $14 million and $13 million to our defined benefit plans during the six months ended June 30, 2016 and 2015, respectively. Additional contributions ranging between approximately $11 million and $21 million are expected during the remainder of 2016.

18


Note 14. Share-Based Compensation Plans
Share-based compensation expense was $5 million and $10 million during the three and six months ended June 30, 2016, respectively, and $4 million and $8 million during the three and six months ended June 30, 2015, respectively. The unrecognized compensation expense related to our stock options, restricted stock units and performance-based shares was $7 million, $22 million and $11 million, respectively, at June 30, 2016 and is expected to be recognized over a weighted average period of 2.1, 1.9 and 2.4 years, respectively. The amount of cash received from the exercise of stock options was $16 million and $9 million for the six months ended June 30, 2016 and 2015, respectively.
Stock Option Grants
The following is a summary of the changes in outstanding stock options for the six months ended June 30, 2016. 
 
Shares             (in thousands)
 
Weighted
Average
Exercise
Price / Share
 
Weighted  Average
Remaining
Contractual
Term (Years)
 
Aggregate Intrinsic Value (in millions)
Outstanding at January 1, 2016
2,561

 
$
31.16

 
6.8
 
 
Granted
460

 
37.83

 
 
 
 
Exercised
(583
)
 
27.30

 
 
 
 
Forfeited and expired
(19
)
 
37.00

 
 
 
 
Outstanding at June 30, 2016
2,419

 
$
33.31

 
7.3
 
$
28

Options exercisable at June 30, 2016
1,440

 
$
30.76

 
6.1
 
$
20

Vested and expected to vest as of June 30, 2016
2,315

 
$
33.13

 
7.2
 
$
27

The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the six months ended June 30, 2016 was $7 million.
Stock Option Fair Value
The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions for 2016 grants.
Volatility
28.89

%
Risk-free interest rate
1.41

%
Dividend yield
1.64

%
Expected term (in years)
5.6

 
Weighted-average fair value / share
$
9.04

 
Expected volatility is calculated based on a weighted analysis of historic and implied volatility measures for a set of peer companies and Xylem. We use historical data to estimate option exercise and employee termination behavior within the valuation model. Employee groups and option characteristics are considered separately for valuation purposes. The expected term represents an estimate of the period of time options are expected to remain outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of option grant.

19


Restricted Stock Unit Grants
The following is a summary of restricted stock units activity for the six months ended June 30, 2016. The fair value of the restricted stock units is equal to the closing share price on the date of the grant. 
(shares in thousands)
Shares
 
Weighted
Average
Grant Date
Fair Value /Share
Outstanding at January 1, 2016
1,013

 
$
34.52

Granted
280

 
38.19

Vested
(281
)
 
29.38

Forfeited
(53
)
 
36.54

Outstanding at June 30, 2016
959

 
$
36.99

ROIC Performance-based Share Grants
The following is a summary of Return on Invested Capital ("ROIC") performance-based share grants for the six months ended June 30, 2016. The fair value of the ROIC performance-based shares is equal to the closing share price on the date of the grant. 
(shares in thousands)
Shares
 
Weighted
Average
Grant Date
Fair Value /Share
Outstanding at January 1, 2016
160

 
$
35.48

Granted
110

 
37.80

Vested

 

Forfeited
(18
)
 
27.49

Outstanding at June 30, 2016
252

 
$
37.09

The following is a summary of our Total Shareholder Return ("TSR") performance-based share grants for the six months ended June 30, 2016.
(shares in thousands)
Shares
 
Weighted
Average
Grant Date
Fair Value /Share
Outstanding at January 1, 2016

 
$

Granted
110

 
45.98

Vested

 

Forfeited

 

Outstanding at June 30, 2016
110

 
$
45.98

TSR Performance-based Share Fair Value
The fair value of TSR performance-based shares was calculated on the date of grant using a Monte Carlo simulation model utilizing several key assumptions, including expected Company and peer company share price volatility, correlation coefficients between peers, the risk-free rate of return, the expected dividend yield and other award design features. The following are weighted-average assumptions for 2016 grants.
Volatility
31.7
%
Risk-free interest rate
0.88
%
Dividend yield
1.64
%

20


Note 15. Capital Stock
On August 24, 2015, our Board of Directors authorized the repurchase of up to $500 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. There were no shares repurchased under this program during the three and six months ended June 30, 2016. There are up to $420 million in shares that may still be purchased under this plan as of June 30, 2016.
On August 20, 2013, the Board of Directors authorized the repurchase of up to $250 million in shares with no expiration date. The program's objective was to deploy our capital in a manner that benefited our shareholders and maintained our focus on growth. There were no shares repurchased under this program during the three months ended June 30, 2015. During the six months ended June 30, 2015, we repurchased 1.4 million shares for $50 million under this program. As of December 31, 2015, we have exhausted the authorized amount to repurchase shares under this plan.
On August 18, 2012, our Board of Directors authorized the repurchase of up to 2.0 million shares of common stock with no expiration date. The program's objective is to offset dilution associated with various Xylem employee stock plans by acquiring shares in the open market from time to time. There were no shares repurchased under this program during the three and six months ended June 30, 2016 and 2015. There are up to 0.3 million shares (approximately $11 million in value) that may still be purchased under this plan as of June 30, 2016.
Aside from the aforementioned repurchase programs, we repurchased less than 0.1 million and 0.1 million shares for less than $1 million and $3 million for the three and six months ended June 30, 2016 and 2015, respectively, in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock units.

21


Note 16. Accumulated Other Comprehensive Income (Loss)
The following table provides the components of accumulated other comprehensive income (loss) for the three months ended June 30, 2016:
(in millions)
Foreign Currency Translation
 
Postretirement Benefit Plans
 
Derivative Instruments
 
Total
Balance at April 1, 2016
$
(32
)
 
$
(185
)
 
$
5

 
$
(212
)
Foreign currency translation adjustment
(29
)
 

 

 
(29
)
Tax on foreign currency translation adjustment
(8
)
 

 

 
(8
)
Amortization of net actuarial loss on postretirement benefit plans into:
 
 
 
 
 
 
 
Cost of revenue

 
1

 

 
1

Selling, general and administrative expenses

 
1

 

 
1

Unrealized loss on derivative hedge agreements

 

 
(4
)
 
(4
)
Reclassification of unrealized gain on derivative hedge agreements into revenue

 

 
(1
)
 
(1
)
Balance at June 30, 2016
$
(69
)
 
$
(183
)
 
$

 
$
(252
)
The following table provides the components of accumulated other comprehensive income (loss) for the six months ended June 30, 2016:
(in millions)
Foreign Currency Translation
 
Postretirement Benefit Plans
 
Derivative Instruments
 
Total
Balance at January 1, 2016
$
(43
)
 
$
(185
)
 
$
(10
)
 
$
(238
)
Foreign currency translation adjustment
(17
)
 

 

 
(17
)
Tax on foreign currency translation adjustment
2

 

 

 
2

Amortization of net actuarial loss on postretirement benefit plans into:
 
 
 
 
 
 
 
Cost of revenue

 
2

 

 
2

Selling, general and administrative expenses

 
3

 

 
3

Income tax impact on amortization of postretirement benefit plan items

 
(3
)
 

 
(3
)
Reclassification of unrealized gain on derivative hedge agreements into cost of revenue

 

 
(1
)
 
(1
)
Reclassification of unrealized loss on net investment hedge
(11
)
 

 
11

 

Balance at June 30, 2016
$
(69
)
 
$
(183
)
 
$

 
$
(252
)
Note 17. Commitments and Contingencies
Legal Proceedings
From time to time, we are involved in legal proceedings that are incidental to the operation of our businesses, including acquisitions and divestitures, intellectual property matters, product liability and personal injury claims, employment and pension matters, government and commercial contract disputes.
On or about February 17, 2009, following a statement submitted to the Spanish Competition Authority (Comision Nacional de la Competencia, "CNC") by Grupo Industrial Ercole Marelli, S.A. regarding an anti-competitive agreement in which it said it had been participating, the CNC conducted an investigation at ITT Water & Wastewater España S.A. (now named Xylem Water Solutions España S.A.), at the Spanish Association of Fluid Pump Manufacturers (the "Association"), and at the offices of other members of the Association. On September 16, 2009, the Directorate of Investigation of the CNC commenced formal proceedings for alleged restrictive practices allegedly prohibited under applicable law. Following the conclusion of the formal proceedings, the CNC

22


Council imposed fines on the Association and nineteen Spanish manufacturers and distributors of fluid pumps, including a fine of Euro 2.4 million applied to ITT Water & Wastewater España S.A. and ITT Corporation. The Company's appeals of the decision were rejected and the fine was paid in March 2016. This matter is now closed.
From time to time claims may be asserted against Xylem alleging injury caused by any of our products resulting from asbestos exposure. We believe there are numerous legal defenses available for such claims and would defend ourselves vigorously. Pursuant to the Distribution Agreement among ITT, Exelis and Xylem, ITT has an obligation to indemnify, defend and hold Xylem harmless for asbestos product liability matters, including settlements, judgments, and legal defense costs associated with all pending and future claims that may arise from past sales of ITT’s legacy products. We believe ITT remains a substantial entity with sufficient financial resources to honor its obligations to us.
Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claims, we do not expect that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on our results of operations, or financial condition.
Indemnifications
As part of our 2011 spin-off from our former parent, ITT, Exelis Inc. and Xylem will indemnify, defend and hold harmless each of the other parties with respect to such parties’ assumed or retained liabilities under the Distribution Agreement and breaches of the Distribution Agreement or related spin agreements. The former parent’s indemnification obligations include asserted and unasserted asbestos and silica liability claims that relate to the presence or alleged presence of asbestos or silica in products manufactured, repaired or sold prior to October 31, 2011, the Distribution Date, subject to limited exceptions with respect to certain employee claims, or in the structure or material of any building or facility, subject to exceptions with respect to employee claims relating to Xylem buildings or facilities. The indemnification associated with pending and future asbestos claims does not expire. Xylem has not recorded a liability for material matters for which we expect to be indemnified by the former parent or Exelis Inc. through the Distribution Agreement and we are not aware of any claims or other circumstances that would give rise to material payments from us under such indemnifications. On May 29, 2015, Harris Inc. acquired Exelis.  As the parent of Exelis, Harris Inc. is responsible for Exelis’s indemnification obligations under the Distribution Agreement.
Guarantees
We obtain certain stand-by letters of credit, bank guarantees and surety bonds from third-party financial institutions in the ordinary course of business when required under contracts or to satisfy insurance related requirements. As of June 30, 2016 and December 31, 2015, the amount of stand-by letters of credit, bank guarantees and surety bonds was $176 million and $161 million, respectively.
Environmental
In the ordinary course of business, we are subject to federal, state, local, and foreign environmental laws and regulations. We are responsible, or are alleged to be responsible, for ongoing environmental investigation and remediation of sites in various countries. These sites are in various stages of investigation and/or remediation and in many of these proceedings our liability is considered de minimis. We have received notification from the U.S. Environmental Protection Agency, and from similar state and foreign environmental agencies, that a number of sites formerly or currently owned and/or operated by Xylem or for which we are responsible under the Distribution Agreement, and other properties or water supplies that may be or have been impacted from those operations, contain disposed or recycled materials or wastes and require environmental investigation and/or remediation. These sites include instances where we have been identified as a potentially responsible party under federal and state environmental laws and regulations.
Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. Our accrued liabilities for these environmental matters represent the best estimates related to the investigation and remediation of environmental media such as water, soil, soil vapor, air and structures, as well as related legal fees. These estimates, and related accruals, are reviewed quarterly and updated for progress of investigation and remediation efforts and changes in facts and legal circumstances. Liabilities for these environmental expenditures are recorded on an undiscounted basis. We have estimated and accrued $4 million as of both June 30, 2016 and December 31, 2015 for environmental matters.

23


It is difficult to estimate the final costs of investigation and remediation due to various factors, including incomplete information regarding particular sites and other potentially responsible parties, uncertainty regarding the extent of investigation or remediation and our share, if any, of liability for such conditions, the selection of alternative remedial approaches, and changes in environmental standards and regulatory requirements. We believe the total amount accrued is reasonable based on existing facts and circumstances.
Warranties
We warrant numerous products, the terms of which vary widely. In general, we warrant products against defect and specific non-performance. The table below provides the changes in our product warranty accrual.
(in millions)
2016
 
2015
Warranty accrual – January 1
$
33

 
$
31

Net changes for product warranties in the period
13

 
14

Settlement of warranty claims
(15
)
 
(13
)
Foreign currency and other
1

 
(1
)
Warranty accrual - June 30
$
32

 
$
31

Note 18. Segment Information
Our business has two reportable segments: Water Infrastructure and Applied Water. The Water Infrastructure segment, focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment, encompasses the uses of water and focuses on the residential, commercial, industrial and agriculture markets offering a wide range of products, including pumps, valves and heat exchangers.
Additionally, we have Regional selling locations consist primarily of selling and marketing organizations and related support that offer products and services across both of our reportable segments. Corporate and other consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs, as well as charges related to certain matters, such as environmental matters that are managed at a corporate level and are not included in the business segments in evaluating performance or allocating resources.

24


The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 in the 2015 Annual Report). The following tables contain financial information for each reportable segment:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(in millions)
2016
 
2015
 
2016
 
2015
Revenue:
 
 
 
 
 
 
 
Water Infrastructure
$
566

 
$
551

 
$
1,080

 
$
1,051

Applied Water
366

 
369

 
699

 
706

Total
$
932

 
$
920

 
$
1,779

 
$
1,757

Operating Income:
 
 
 
 
 
 
 
Water Infrastructure
$
70

 
$
65

 
$
124

 
$
112

Applied Water
51

 
51

 
90

 
97

Corporate and other
(12
)
 
(12
)
 
(26
)
 
(22
)
Total
$
109

 
$
104

 
$
188

 
$
187

Depreciation and Amortization:
 
 
 
 
 
 
 
Water Infrastructure
$
21

 
$
23

 
$
43

 
$
48

Applied Water
6

 
6

 
12

 
12

Regional selling locations (a)
4

 
3

 
6

 
5

Corporate and other
2

 
2

 
4

 
4

Total
$
33

 
$
34

 
$
65

 
$
69

Capital Expenditures:
 
 
 
 
 
 
 
Water Infrastructure
$
15

 
$
12

 
$
34

 
$
37

Applied Water
3

 
3

 
11

 
10

Regional selling locations (b)
5

 
4

 
15

 
6

Corporate and other
1

 
1

 
2

 
4

Total
$
24

 
$
20

 
$
62

 
$
57

(a)
Depreciation and amortization expense incurred by the Regional selling locations was included in an overall allocation of Regional selling location costs to the segments; however, a certain portion of that expense was not specifically identified to a segment. That expense is captured in this Regional selling location line.
(b)
Represents capital expenditures incurred by the Regional selling locations not allocated to the segments.
The following table contains the total assets for each reportable segment: 
(in millions)
June 30,
2016
 
December 31,
2015
Water Infrastructure
$
2,109

 
$
2,024

Applied Water
1,048

 
1,054

Regional selling location (a)
969

 
905

Corporate and other (b)
568

 
674

Total
$
4,694

 
$
4,657

(a)
The Regional selling locations have assets that consist primarily of cash, accounts receivable and inventory which are not allocated to the segments.
(b)
Corporate and other consists of items pertaining to our corporate headquarters function, which principally consist of cash, deferred tax assets, pension assets and certain property, plant and equipment.

25


ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the condensed consolidated financial statements, including the notes thereto, included elsewhere in this report on Form 10-Q (this "Report"). Except as otherwise indicated or unless the context otherwise requires, "Xylem," "we," "us," "our" and the "Company" refer to Xylem Inc. and its subsidiaries. References in the condensed consolidated financial statements to "ITT" or the "former parent" refer to ITT Corporation (now ITT Inc.) and its consolidated subsidiaries (other than Xylem Inc.).
This Report contains information that may constitute “forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenue, operating margins and earnings per share growth, and statements expressing general views about future operating results - are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.
Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions, political and other risks associated with our international operations, including military actions, economic sanctions or trade embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates;  competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 ("2015 Annual Report") and with subsequent filings we make with the Securities and Exchange Commission ("SEC").
All forward-looking statements made herein are based on information available to the Company as of the date of this Report.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the reporting periods included herein are described as ending on the last day of the calendar quarter.
Overview
Xylem is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. Our business focuses on providing technology-intensive equipment and services. Our product and service offerings are organized into two reportable segments: Water Infrastructure and Applied Water. Our segments are aligned with each of the sectors in the cycle of water, water infrastructure and usage applications.
Water Infrastructure serves the water infrastructure sector with pump systems that transport water from aquifers, lakes, rivers and seas; with filtration, ultraviolet and ozone systems that provide treatment, making the water fit to use; and pumping solutions that move the wastewater to treatment facilities where our mixers, biological treatment, monitoring and control systems provide the primary functions in the treatment process. We provide analytical instrumentation used to measure water quality, flow and level in wastewater, surface water and coastal environments. In the Water Infrastructure segment, we

26


provide the majority of our sales directly to customers with strong application expertise, while the remaining amount is through distribution partners.
Applied Water serves the usage applications sector with water pressure boosting systems for heating, ventilation and air conditioning and for fire protection systems to the residential and commercial building services markets. In addition, our pumps, heat exchangers, valves and controls provide cooling to power plants and manufacturing facilities, as well as circulation for food and beverage processing. We also provide boosting systems for farming irrigation, pumps for dairy operations and rainwater reuse systems for small scale crop and turf irrigation. In the Applied Water segment, we provide the majority of our sales through long-standing relationships with the world’s leading distributors, with the remainder going directly to customers.
We sell our equipment and services through direct and indirect channels that serve the needs of each customer type. In the Water Infrastructure segment, we provide the majority of our sales direct to customers with strong application expertise, while the remaining amount is through distribution partners. In the Applied Water segment, we provide the majority of our sales through long-standing relationships with the world’s leading distributors, with the remainder going direct to customers.
Executive Summary
Xylem reported revenue for the second quarter of 2016 of $932 million, an increase of 1.3% compared to $920 million during the second quarter of 2015. Revenue increased 2.7% on a constant currency basis due to organic growth of 1.5% mostly in the public utility market as well as some commercial market growth, partially offset by declines in the remaining served markets and contributions of 1.2% from the recent acquisitions within our Water Infrastructure segment. Operating income for the second quarter of 2016 was $109 million, reflecting an increase of 4.8% compared to $104 million in the second quarter of 2015. Operating margin was 11.7% for 2016 versus 11.3% for 2015, an increase of 40 basis points. Excluding restructuring and realignment charges and special charges, which increased $5 million and $1 million in the second quarter as compared to the prior year, respectively, operating income was $121 million with an operating margin of 13.0% in 2016 as compared to operating income of $110 million with an operating margin of 12.0%. This increase in adjusted operating margin was due to cost reductions and increased volume, partially offset by cost inflation and strategic investments.
Additional financial highlights for the quarter ended June 30, 2016 include the following:
Orders of $923 million, or 2.2% decline from $944 million in the prior year, though down 1.8% on an organic basis
Earnings per share of $0.39, down 4.9% from the prior year ($0.48 on an adjusted basis, up 11.6%)
Cash flow from operating activities of $125 million for the six months ended June 30, 2016, up 1.6% from prior year, and free cash flow of $63 million as compared to $66 million in the prior year, down 4.5%
Key Performance Indicators and Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margin, segment operating income and margins, earnings per share, orders growth, working capital, free cash flow and backlog, among others. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including, but not limited to, dividends, acquisitions, share repurchases and debt repayment. However, other than with respect to total revenue, we only provide guidance on a non-GAAP basis and do not provide reconciliations of such forward-looking measures to GAAP due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as, integration and acquisition-related costs, special charges and tax related special items. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators: 
"organic revenue" and "organic orders" defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for

27


classification as a discontinued operation. The period-over-period change resulting from foreign currency translation assumes no change in exchange rates from the prior period.
"constant currency" defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. Dollar.
"adjusted net income" and "adjusted earnings per share" defined as net income and earnings per share, respectively, adjusted to exclude restructuring and realignment costs, special charges, tax-related special items and gain from sale of businesses. A reconciliation of adjusted net income is provided below.
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(In millions, except for per share data)
2016
 
2015
 
2016
 
2015
Net income
$
71

 
$
74

 
$
137

 
$
138

Restructuring and realignment, net of tax benefit of $3 and $5 for 2016 $1 and $3 for 2015
8

 
5

 
15

 
9

Special charges, net of tax benefit of $4 and $5 for 2016 and $0 for 2015
5

 
1

 
8

 
3

Tax-related special items
3

 
(2
)
 
(11
)
 
(3
)
Gain from sale of businesses, net of $0 tax

 

 

 
(9
)
Adjusted net income
$
87

 
$
78

 
$
149

 
$
138

Weighted average number of shares - Diluted
179.9

 
182.3

 
179.6

 
182.7

Adjusted earnings per share
$
0.48

 
$
0.43

 
$
0.83

 
$
0.76

"operating expenses excluding restructuring and realignment costs and special charges" defined as operating expenses, adjusted to exclude restructuring and realignment costs, and special charges.
"adjusted operating income (loss)" defined as operating income (loss), adjusted to exclude restructuring and realignment costs and special charges, and "adjusted operating margin" defined as adjusted operating income divided by total revenue.
“realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“special charges” defined as costs incurred by the Company, such as interest expense related to the early extinguishment of debt during Q2 2016, initial acquisition related costs, costs incurred for the contractual indemnification of tax obligations to ITT and other special non-operating items.
"tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.
"free cash flow" defined as net cash from operating activities, as reported in the Condensed Consolidated Statements of Cash Flows, less capital expenditures, as well as adjustments for other significant items that impact current results that management believes are not related to our ongoing operations and performance. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt. The following table provides a reconciliation of free cash flow.
 
Six Months Ended
 
June 30,
(In millions)
2016
 
2015
Net cash provided by operating activities
$
125

 
$
123

Capital expenditures
(62
)
 
(57
)
Free cash flow
$
63

 
$
66


28



2016 Outlook
We continue to anticipate organic revenue growth in the low single digits in 2016. The following is a summary of our outlook by market.
Industrial market performance decreased 3% through the first half of the year due to continued decreases in the oil and gas market as well as weakness in the mining market driven by dewatering declines. We expect growth to be flat for the year. This projection assumes low-single-digit growth in light industrial applications, and double-digit declines in oil and gas, and mining applications.
Through the first half of the year, public utilities increased 13%.  We expect growth in the high-single-digits for 2016 due in part to tougher comparisons in the second half of the year. We anticipate continued growth in the United States, western Europe and across emerging markets.
In the commercial markets, growth was 3% through the first half of the year driven by strong performance in Europe and Canada, partially offset by declines in China. We expect growth in the mid-single-digit range for the year. We anticipate second half performance to be driven by improving market conditions in the United States and continued growth in Europe, due to demand for new products.
Residential markets declined 5% for the first half of the year driven by Asia Pacific and the Middle East. We anticipate challenging market conditions to continue over the balance of the year and, as a result, full year performance will be down in the mid-single-digits.
Our agriculture markets, which is our smallest end market, declined 5% through the first half of the year. We expect 2016 to be down in the mid-single-digits as we will likely continue to see unfavorable market conditions.
We will continue to execute restructuring and realignment actions to reposition our European and North American businesses in an effort to optimize our cost structure and improve our operational efficiency and effectiveness. During 2016, we expect to incur approximately $25 million in restructuring and realignment costs. We expect to realize approximately $1 million of incremental net savings in 2016 from actions initiated in 2015, and an additional $10 million of net savings from our 2016 actions.
Additional strategic actions we are taking include initiatives to drive above-market growth, advance continuous improvement activities to increase productivity, focus on improving cash performance and drive a disciplined capital deployment strategy.

29


Results of Operations
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(In millions)
2016
 
2015
 
Change
 
2016
 
2015
 
Change
Revenue
$
932

 
$
920

 
1.3

%
 
$
1,779

 
$
1,757

 
1.3

%
Gross profit
369

 
348

 
6.0

%
 
698

 
663

 
5.3

%
Gross margin
39.6
%
 
37.8
%
 
180

bp 
 
39.2
%
 
37.7
%
 
150

bp 
Operating expenses excluding restructuring and realignment costs and special charges
248

 
238

 
4.2

%
 
485

 
463

 
4.8

%
Expense to revenue ratio
26.6
%
 
25.9
%
 
70

bp 
 
27.3
%
 
26.4
%
 
90

bp 
Restructuring and realignment costs
11

 
6

 
83.3

%
 
20

 
12

 
66.7

%
Special charges
1

 

 
NM

 
 
5

 
1

 
400.0

%
Total operating expenses
260

 
244

 
6.6

%
 
510

 
476

 
7.1

%
Operating income
109

 
104

 
4.8

%
 
188

 
187

 
0.5

%
Operating margin
11.7
%
 
11.3
%
 
40

bp 
 
10.6
%
 
10.6
%
 

bp 
Interest and other non-operating expense, net
19

 
13

 
46.2

%
 
33

 
28

 
17.9

%
Gain on sale of businesses

 

 
NM

 
 

 
9

 
NM

 
Income tax expense
19

 
17

 
11.8

%
 
18

 
30

 
(40.0
)
%
Tax rate
21.6
%
 
18.1
%
 
350

bp 
 
11.8
%
 
17.8
%
 
(600
)
bp 
Net income
$
71

 
$
74

 
(4.1
)
%
 
$
137

 
$
138

 
(0.7
)
%
NM - Not meaningful percentage change
Revenue
Revenue generated during the three and six months ended June 30, 2016 was $932 million and $1,779 million, reflecting increases of $12 million or 1.3% and $22 million or 1.3%, respectively, compared to the same prior year periods. On a constant currency basis, revenue grew 2.7% and 3.5% for the three and six months ended June 30, 2016. These increases reflect strong organic growth within western Europe for both periods, particularly in Germany and the United Kingdom, and organic growth in the United States for the first half of the year. Emerging markets also contributed to the organic growth in both periods, particularly in India and the Middle East region.
The following table illustrates the impact from organic growth, recent acquisitions, and foreign currency translation in relation to revenue during the three and six months ended June 30, 2016:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
(In millions)
Change
 
% Change
 
Change
 
% Change
2015 Revenue
$
920

</